Chaipan, Chawaree, Dilley, Kari A, Paprotka, Tobias et al. · Journal of virology · 2011 · DOI
This study investigated how XMRV, a virus found in some CFS patients, behaves when it infects human immune cells called PBMCs. Researchers discovered that human immune cells have natural defenses (proteins called APOBEC3G and APOBEC3F) that can damage the virus's genetic material and prevent it from spreading effectively. Although the virus could technically survive in these cells, it could not replicate well—suggesting the body has built-in brakes that limit XMRV's ability to cause ongoing infection.
Understanding XMRV's restricted replication in human immune cells is fundamental to evaluating XMRV's role in CFS pathogenesis. This work clarifies a key discrepancy: why infectious XMRV could be detected in CFS patient samples despite poor replication in primary immune cells, informing interpretations of XMRV viral load studies and the biological plausibility of persistent XMRV infection in CFS.
This study does not prove that XMRV causes CFS or that it persists as a clinically significant infection in CFS patients. The research is limited to in vitro cell culture systems and does not demonstrate whether the observed restriction mechanisms function equivalently in vivo or whether they adequately clear XMRV from infected individuals. Correlation of viral hypermutation with human PBMC infection remains an inference rather than a validated biomarker.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →